Furthermore, Chan et al. showed that in a subpopulation of EGFR-mutated NSCLC patients, baseline NLR was recognized as an independent prognostic factor across early- and late-stage disease [35]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.